[MYDOCALM TREATMENT OF PSEUDO-PARKINSON DISORDERS FOLLOWING THE ADMINISTRATION OF NEUROLEPTIC AGENTS].
D014150:Antipsychotic Agents; D004358:Drug Therapy; D010276:Parasympatholytics; D010300:Parkinson Disease; D020734:Parkinsonian Disorders; D011427:Propiophenones; D014049:Tolperisone; D014116:Toxicology; D014149:Tranquilizing Agents
D014150:Antipsychotic Agents; D010276:Parasympatholytics; D011427:Propiophenones; D014149:Tranquilizing Agents; D014049:Tolperisone
DRUG THERAPY; PARASYMPATHOLYTICS; PARKINSONISM; PROPIOPHENONES; TOXICOLOGIC REPORT; TRANQUILIZING AGENTS
TRAITEMENT PAR LE MYDOCALM DES TROUBLES PSEUDO-PARKINSONNIENS SECONDAIRES 'A L'ADMINISTRATION DES NEUROLEPTIQUES.